Amneal to Report Second Quarter 2025 Results on August 5, 2025

Core Viewpoint - Amneal Pharmaceuticals, Inc. will release its second quarter 2025 financial results on August 5, 2025, prior to market open, and will host an audio webcast at 8:30 a.m. ET [1] Company Overview - Amneal Pharmaceuticals, Inc. is a global biopharmaceutical company headquartered in Bridgewater, NJ, with a diverse portfolio of over 280 pharmaceuticals primarily in the United States [3] - The company operates in multiple segments, including Affordable Medicines, which focuses on complex product categories and therapeutic areas such as injectables and biosimilars, and Specialty, which has a growing portfolio of branded pharmaceuticals targeting central nervous system and endocrine disorders [3] - Through its AvKARE segment, Amneal distributes pharmaceuticals and other products for the U.S. federal government, retail, and institutional markets [3] Investor Relations - The financial results and live webcast will be accessible through the Investor Relations section of the company's website [2] - Individuals can register for the webcast and access the call through a conference line with specific dialing instructions provided [2]